MedTrace Logo

Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease

NCT00898508 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 563

Last updated 2025-06-25

No results posted yet for this study

Summary

RATIONALE: Collecting and storing samples of blood and tumor tissue from patients with cancer to test in the laboratory may help the study of cancer in the future.

PURPOSE: This clinical trial is studying blood and tumor tissue samples in women with invasive breast cancer, ductal carcinoma in situ, lobular carcinoma in situ, or benign breast disease.

Conditions

Interventions

GENETIC

gene expression analysis

GENETIC

mutation analysis

GENETIC

proteomic profiling

GENETIC

reverse transcriptase-polymerase chain reaction

OTHER

fluorescent antibody technique

OTHER

immunohistochemistry staining method

OTHER

laboratory biomarker analysis

OTHER

liquid chromatography

OTHER

mass spectrometry

OTHER

medical chart review

PROCEDURE

quality-of-life assessment

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • City of Hope Medical Center

    lead OTHER

Principal Investigators

  • Robert Hickey, Ph.D. · City of Hope Comprehensive Cancer Center

Eligibility

Min Age
20 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-08-31
Primary Completion
2019-06-06
Completion
2019-06-06

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00898508 on ClinicalTrials.gov